E-learningNews & eventsSpeakersPartners
Sign in
Sign in
Social media
Main pages
  • News & events
  • Speakers
  • Partners
  • Reviews
E-learning
  • Courses
  • Lectures
Corporate website
  • Sona Group

Contacts

  • info@sona-pharm.eu
  • Business days 9:00-17:00 EET
  • +372 505 9699
  • Ahtri 6, Tallinn, 10151, Estonia

Sona Group unites a network of independent pharmaceutical and healthcare companies operating in research, manufacturing and continued medical education.

This website is intended for informational and corporate communication purposes only and is not a substitute for medical advice.

© 2026 Sona Academy®. All rights reserved.

··Site map
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Legal Notice
  • Professional Medical Disclaimer
  • Data Collection and Privacy Disclaimer
Reproductive healthLecture

Overweight, obesity and reproductive outcomes

32 minAudio: EN · UA · RUSubtitles: EN · UA · RU
Player.aboutHeading

Christophe Blockeel examines the impact of overweight and obesity on reproductive outcomes — a topic often reduced in clinic to "lose weight," though the data demand a far more nuanced approach.

The first and perhaps most important thesis is a J-shaped curve: both excess and insufficient body weight lower fertility. The extremes on either side are equally undesirable, so the conversation with a patient must cover not only "extra kilos" but also low body mass.

The male factor cannot be set aside. A man's waist circumference correlates with worse semen parameters and higher sperm DNA fragmentation, so metabolic health is a shared task for the couple, not the woman's alone.

The scale of the problem is shown by large SART data on 239,000 cycles: as BMI rises, implantation, pregnancy and live-birth rates fall consistently. These are not isolated observations but statistics one can rely on.

The donor-oocyte argument is especially telling: in donor-egg recipients the negative effect of excess weight persists. So it is not only about oocyte quality — the endometrium, the maternal side of implantation, is involved too.

The paradox of interventions: weight-loss programmes (diet, physical activity) in trials did not improve IVF outcomes as such, yet they did raise the rate of spontaneous conception in the same patients.

This is an important nuance for honest counselling. Lifestyle correction is certainly valuable — for general health and for natural fertility — but promising a better outcome for a specific IVF cycle through it would be incorrect.

The speaker's main practical message is to move from BMI to body-composition assessment: bioimpedance, calorimetry. BMI does not distinguish muscle from fat and therefore poorly predicts true metabolic and reproductive risk.

Body composition more accurately reflects the metabolic background that affects oocyte quality, endometrial receptivity and the subsequent course of pregnancy, including obstetric risks in women with obesity.

Hence a more honest and individual approach to the couple: assess metabolic risk and body composition rather than the number on the scale, and plan interventions with realistic rather than inflated expectations for a given cycle.

This view also removes part of the stigma: the problem is not the patient's "willpower" but a measurable metabolic state that can be influenced systematically and in advance, before entering the programme.

The upshot: weight affects fertility on both sides of the curve and through both partners; the assessment tool should shift from BMI to body composition, and the goal of intervention is the couple's health, not just the outcome of one transfer.

Topics covered
  • BMI as an outdated criterion
  • Body composition assessment
  • Bioelectrical impedance and indirect calorimetry
  • Couple-level fertility (male obesity)
  • Sustainable weight loss vs starvation diets
  • Obstetric vs embryologic risk thresholds
  • Underweight subgroup and malnutrition
Watch the lesson
About the course

The impact of overweight and obesity on reproductive outcomes: ovarian response, embryo quality, endometrial receptivity and obstetric consequences. Why BMI alone is insufficient for clinical decisions — and how body composition assessment (bioelectrical impedance, indirect calorimetry, food diary) makes pre-cycle workup truly individualized.

The impact of overweight and obesity on reproductive outcomes: ovarian response, embryo quality, endometrial receptivity and obstetric consequences. Why BMI alone is insufficient for clinical decisions — and how body composition assessment (bioelectrical impedance, indirect calorimetry, food diary) makes pre-cycle workup truly individualized.

What you will learn

Replace BMI with body composition assessment

Use bioelectrical impedance, indirect calorimetry and food diary to individualise pre-cycle counselling.

Counsel couples on joint metabolic risk

Address male partner obesity as part of fertility planning, not only female BMI.

Recommend sustainable weight management over crash diets

Recognise that starvation diets worsen oxidative stress and oocyte quality.

Stratify cycle start by obstetric versus embryologic risk

Apply unit-specific BMI thresholds with attention to obstetric safety, not embryologic gain alone.

Who is this course for
  • Reproductive endocrinologists and ART specialists
  • Gynecologists managing infertility patients
  • ART fellows and embryologists with clinical focus
Christophe Blockeel

Christophe Blockeel

Reproductive endocrinologist and gynecologist, and Medical Director of Brussels IVF — the Centre for Reproductive Medicine at University Hospital Brussels (UZ Brussel). Professor at the Vrije Universiteit Brussel and visiting professor at the University of Zagreb, with more than 20 years in reproductive medicine. His work focuses on ovarian stimulation, embryo transfer and assisted reproductive technologies, with more than 300 scientific publications.

Author of the lecture "Overweight, obesity and reproductive outcomes"

Continue your learning

View all programs
View all programs
Sona Academy Online Webinar
Webinar • AI in Reproductive Medicine
44d 14hReproductive healthLecture

AI in Reproductive Medicine

Patients arrive at the clinic already having consulted ChatGPT, and regulators are reviewing the first AI ‘doctors’. What in artificial intelligence already works in reproductive medicine — from assistant avatars to embryo assessment and stimulation personalisation? A live discussion on three levels — strategy, service and clinic — with practical cases and a panel Q&A.

Christos Venetis
Christos Venetis
Sona-Pharm grant award • Ceremony — July 2027, Stockholm
Fertility Award 2027 • Applications open 1 Feb 2027
280d 7hReproductive healthLecture

Fertility Award 2027

A Sona-Pharm grant award for specialists in infertility treatment. Applications open on 1 February 2027. Ceremony — July 2027, Stockholm, during the ESHRE meeting.

Mykola Gryshchenko
Mykola Gryshchenko
UARM Symposium • 22.05.2026
Lecture • Immunotropic therapy in reproductive medicine
Reproductive healthLecture

Immunotropic therapy in reproductive medicine

Targeted, biomarker-guided immunotropic therapy in reproductive medicine. A lecture by Kseniia Khazhylenko at the UARM Symposium 2026.

Audio: UASubtitles: UA32 min

Kseniia Khazhylenko
Kseniia Khazhylenko